Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilmar Reis

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19 - Author's replyGilmar Reis, Edward Mills
Lancet (London, England)|March 18, 2022
Evaluating COVID-19 vaccines in the real worldEdward J Mills, Gilmar Reis
The New England Journal of Medicine|December 14, 2022
Ivermectin Treatment for Covid-19. ReplyGilmar Reis, Edward J Mills
The New England Journal of Medicine|May 31, 2023
Pegylated Interferon Lambda for Covid-19. ReplyGilmar Reis, Edward J Mills, Jeffrey S Glenn
Journal of the American College of Cardiology|March 12, 2004
Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosisGilmar Reis, Mauro S Motta, Marcia M Barbosa, et al.
The American Journal of Tropical Medicine and Hygiene|January 7, 2022
Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical TrialJamie I Forrest, Angeli Rawat, Felipe Duailibe, et al.
Mededpublish (2016)|December 13, 2023
Incorporating evidence-based principles in medical training. Sharing experience with McMasterSilke Anna Theresa Weber, Aristides Palhares Neto, Luciana Patrícia Abbade, et al.
Arquivos Brasileiros De Cardiologia|October 20, 2009
Dobutamine-stress echocardiography in asymptomatic patients with aortic regurgitationMarcia M Barbosa, Claudia M V Freire, Lúcia M A Fenelon, et al.
The American Journal of Tropical Medicine and Hygiene|November 15, 2022
Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence ModelFergal P Mills, Gilmar Reis, Lindsay A Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2014
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumoniaSamir S Awad, Alejandro H Rodriguez, Yin-Ching Chuang, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Lancet. Global Health|February 18, 2022
Fluvoxamine for the treatment of COVID-19 - Author's replyGilmar Reis, Edward Mills
Lancet (London, England)|March 18, 2022
Evaluating COVID-19 vaccines in the real worldEdward J Mills, Gilmar Reis
The New England Journal of Medicine|December 14, 2022
Ivermectin Treatment for Covid-19. ReplyGilmar Reis, Edward J Mills
The New England Journal of Medicine|May 31, 2023
Pegylated Interferon Lambda for Covid-19. ReplyGilmar Reis, Edward J Mills, Jeffrey S Glenn
Journal of the American College of Cardiology|March 12, 2004
Dobutamine stress echocardiography for noninvasive assessment and risk stratification of patients with rheumatic mitral stenosisGilmar Reis, Mauro S Motta, Marcia M Barbosa, et al.
The American Journal of Tropical Medicine and Hygiene|January 7, 2022
Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical TrialJamie I Forrest, Angeli Rawat, Felipe Duailibe, et al.
Mededpublish (2016)|December 13, 2023
Incorporating evidence-based principles in medical training. Sharing experience with McMasterSilke Anna Theresa Weber, Aristides Palhares Neto, Luciana Patrícia Abbade, et al.
Arquivos Brasileiros De Cardiologia|October 20, 2009
Dobutamine-stress echocardiography in asymptomatic patients with aortic regurgitationMarcia M Barbosa, Claudia M V Freire, Lúcia M A Fenelon, et al.
The American Journal of Tropical Medicine and Hygiene|November 15, 2022
Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence ModelFergal P Mills, Gilmar Reis, Lindsay A Wilson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2014
A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumoniaSamir S Awad, Alejandro H Rodriguez, Yin-Ching Chuang, et al.
Pageof 3